Analysis of
ITGB2
rare germ line variants in chronic lymphocytic leukemia
Blood
.
2017 Nov 30;130(22):2443-2444.
doi: 10.1182/blood-2017-08-800128.
Epub 2017 Oct 19.
Authors
Grace Tiao
1
,
M Reina Improgo
1
2
3
,
Eugen Tausch
4
,
Stacey M Fernandes
2
,
Jasmin Bahlo
5
,
Sandra Robrecht
5
,
Kirsten Fischer
5
,
Michael Hallek
5
,
Stephan Stilgenbauer
4
,
Adam Kiezun
1
,
Gad Getz
1
6
7
8
,
Jennifer R Brown
1
2
3
Affiliations
1
Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, and.
3
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
4
Department of Internal Medicine III, Ulm University, Ulm, Germany.
5
Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany.
6
Center for Cancer Research and.
7
Department of Pathology, Massachusetts General Hospital, Boston, MA; and.
8
Department of Pathology, Harvard Medical School, Boston, MA.
PMID:
29051179
PMCID:
PMC5709789
DOI:
10.1182/blood-2017-08-800128
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
CD18 Antigens*
Germ Cells
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Substances
CD18 Antigens
Grants and funding
R01 CA213442/CA/NCI NIH HHS/United States